Schramme, F., Crosignani, S., Frederix, K., Hoffmann, D., Pilotte, L., Stroobant, V., . . . Van Den Eynde, B. (2019). Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors. American Association for Cancer Research.
Citação do estilo Chicago (17ª ed.)Schramme, F., S. Crosignani, K. Frederix, D. Hoffmann, L. Pilotte, V. Stroobant, J. Preillon, G. Driessens, e B. Van Den Eynde. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.
Citação MLA (9ª ed.)Schramme, F., et al. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.